Factor XIII deficiency and cardiopulmonary bypass: Use of a novel modification of the activated clotting time to monitor anticoagulation

Anesthesiology

Volumn 87, Issue 4, 1997, Pages 990-992

  Gerhardt, Mark A ^b   Greenberg, Charles S ^b   Slaughter, Thomas F ^b   Smith, Mark Stafford ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Activated clotting time; Anticoagulation; Cardiac surgery; Cardiopulmonary bypass; Factor XII; Factor XII deficiency; Heparin; High molecular weight kininogen deficiency; Human; Prekallekrein deficiency

Indexed keywords

AMINOCAPROIC ACID; HEPARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; DRUG MONITORING; HEPARINIZATION; HUMAN; INTRAOPERATIVE PERIOD; MALE; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; BLOOD;

AGED; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; FACTOR XII DEFICIENCY; HEPARIN; HUMANS; MALE; WHOLE BLOOD COAGULATION TIME;

EID: 0030612250     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199710000-00038     Document Type: Article

References (10)

1. Halbmayer WM, Haushofer A, Schon R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M: The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: Evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemostas 1994; 71(1):68-72
2. Halbmayer WM, Haushofer A, Radek J, Schon R, Deutsch M, Fischer M: Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery. Cor Art Disease 1994; 5:451-4
3. Kelsey PR, Bottomley J, Grotte GJ, Maciver JE: Congenital factor XII deficiency: Successful open heart surgery and anticoagulation. Clin Lab Haemat 1985; 7:379-81
4. Salmenpera M, Rasi V, Mattila S: Cardiopulmonary bypass in a patient with Factor XII deficiency. ANESTHESIOLOGY 1991; 75:539-41
5. Moorman RM, Reynolds DS, Comunale ME: Management of cardiopulmonary bypass in a patient With congenital Factor XII deficiency. J Cardiothorac Vasc Anesth 1993; 7(4):452-4
6. Wood MK: Congenital Factor XII deficiency and cardiopulmonary bypass. Ann Thorac Surg 1994; 58:1565
7. Wallock M, Arentzen C: Factor XII deficiency and cardiopulmonary bypass. Perfusion 1995; 10:13-6
8. Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ: in vitro effect of hemodilution on activated clotting time and high-dose thrombin time during Cardiopulmonary bypass. Ann Thorac Surg 1996; 62(2):533-7
9. Kesteven PJ, Pasaoglu I, Williams BT, Savidge GF: Significance of the whole blood activated clotting time in cardiopulmonary bypass. J Cardiovasc Surg 1986; 27(1):85-9
10. Barnette RE, Shupak RC, Pontius J, Rao AK: In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass. Anesth Analg 1988; 67:57-60